Science Explorer Interactive view Map
Hospital / health system · Uozu · Japan

Toyama Rosai Hospital

toyamah.johas.go.jpROR OpenAlex
Research works
58
▲ 52% vs 2013–17
Citations
614
10.6 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Toyama Rosai Hospital is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.18× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 7.99× its world share, 0 worksImmunology and Micro…Neuroscience: 3.14× its world share, 0 worksNeuroscienceEngineering: 0.17× its world share, 0 worksEngineeringMedicine: 4.27× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.0×. Every wedge is a field page.

Which keywords describe research at Toyama Rosai Hospital?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Treatment, Chemotherapy, Diagnosis, Prognostic Factors, Immunohistochemistry, Surgical Management and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 3.5×31 topics
  2. Treatment5▲ 7.1×15 topics
  3. Chemotherapy4▲ 11×10 topics
  4. Diagnosis4▲ 7.0×14 topics
  5. Inflammation4▲ 2.7×14 topics
  6. Prognostic Factors4▲ 13×9 topics
  7. Immunohistochemistry3▲ 62×4 topics
  8. Immunotherapy3▲ 8.5×8 topics
  9. Surgical Management3▲ 12×8 topics
  10. Gastric Cancer3▲ 41×2 topics
  11. Genetic Mutations3▲ 9.3×8 topics
  12. Management2▲ 5.6×8 topics
  13. Antibiotic Resistance2▲ 10.0×2 topics
  14. Molecular Profiling2▲ 33×2 topics
  15. Prevention2▲ 10×3 topics
  16. Complications2▲ 7.2×8 topics
  17. Degenerative Disc Disease2▲ 42×2 topics
  18. Imatinib Mesylate2▲ 65×2 topics
  19. Pathogenesis2▲ 6.4×3 topics
  20. Spinal Fusion2▲ 39×2 topics
  21. Clinical Practice Guidelines2▲ 6.0×6 topics
  22. Fibrosis2▲ 16×4 topics
  23. Heart Failure2▲ 7.5×7 topics
  24. Survival Analysis2▲ 12×2 topics
  25. Breast Cancer2▲ 11×5 topics
  26. Eradication Therapy2▲ 64×1 topic
  27. Guidelines2▲ 6.4×3 topics
  28. Helicobacter pylori2▲ 64×1 topic
  29. Low Back Pain2▲ 19×2 topics
  30. Pedicle Screw Fixation2▲ 74×1 topic
  31. Surgical Treatment2▲ 16×3 topics
  32. Vertebroplasty2▲ 74×1 topic
  33. Molecular Characterization2▲ 16×2 topics
  34. Children2▲ 11×3 topics
  35. Diagnostic Criteria2▲ 13×4 topics
  36. Endoscopic Resection2▲ 29×2 topics
  37. Interstitial Lung Disease2▲ 51×2 topics
  38. Neoadjuvant Therapy2▲ 12×3 topics
  39. PET Imaging2▲ 13×2 topics
  40. Surgery2▲ 8.7×5 topics

Which research topics does Toyama Rosai Hospital publish most on?

By volume in 2022–2025: Metastasis and carcinoma case studies, Colorectal Cancer Treatments and Studies, Cancer Diagnosis and Treatment and Neutrophil, Myeloperoxidase and Oxidative Mechanisms.

Metastasis and carcinoma…0Metastasis and carcinoma case studies: 0 fractional worksColorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksCancer Diagnosis and Treatment: 0 fractional worksNeutrophil, Myeloperoxid…0Neutrophil, Myeloperoxidase and Oxidative Mechanisms: 0 fractional worksVasculitis and related c…0Vasculitis and related conditions: 0 fractional worksIgG4-Related and Inflamm…0IgG4-Related and Inflammatory Diseases: 0 fractional worksInterstitial Lung Diseas…0Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksPotassium and Related Disorders: 0 fractional worksSoft tissue tumor case s…0Soft tissue tumor case studies: 0 fractional works
Pulmonary and Respiratory MedicineOncologyImmunologyRheumatology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 0 works
  2. 2 Colorectal Cancer Treatments and Studies Oncology 0 works
  3. 3 Cancer Diagnosis and Treatment Oncology 0 works
  4. 4 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  5. 5 Vasculitis and related conditions Pulmonary and Respiratory Medicine 0 works
  6. 6 IgG4-Related and Inflammatory Diseases Rheumatology 0 works
  7. 7 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  8. 8 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Potassium and Related Disorders Pulmonary and Respiratory Medicine 0 works
  10. 10 Soft tissue tumor case studies Rheumatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 28% of research is openly available.

with international co-authors2.6%domestic only97.4%

World: 19% is written across borders.

How has Toyama Rosai Hospital's research output changed?

Output in 2018–2022 was 52% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.